Takeda CEO talks globalization, innovation in pharmaceutical industry

Christophe Weber, pres­i­dent and CEO of Takeda Phar­ma­ceu­tical Com­pany Ltd., shared his global vision, mul­ti­cul­tural per­spec­tive, and long-​​term approach to run­ning the 235-​​year-​​old Japanese com­pany on Tuesday at Northeastern’s CEO Break­fast Forum speaker series.

EpiPen’s pricing debacle and its impact on patients, insurers

A firestorm erupted this week in response to the phar­ma­ceu­tical com­pany Mylan’s sharp increase in the price of its EpiPen, a life-​​saving treat­ment for severe allergic reac­tions. The com­pany quickly back­tracked, announcing a rebate plan. Here, three North­eastern fac­ulty members—pharmacist Tayla Rose, health­care finance expert Steven Pizer, and health policy researcher Gary Young—explain the clin­ical, eco­nomic, and policy impli­ca­tions of the controversy.

Influence of Young Scholars Program reverberates through time

As a rising high school senior, assis­tant pro­fessor Matthew Eck­elman, spent a summer at North­eastern sim­u­lating earth­quakes on a shaker table to eval­uate the sta­bility of land­fill liner sys­tems. Twenty-​​one years later, he’s come full circle, hosting young scholars in his lab, guiding them toward STEM careers.